Zymaxid FDA Approval History
FDA Approved: Yes (First approved May 18, 2010)
Brand name: Zymaxid
Generic name: gatifloxacin
Dosage form: Ophthalmic Solution
Company: Allergan plc
Treatment for: Conjunctivitis, Bacterial
Zymaxid (gatifloxacin ophthalmic) is a fluoroquinolone anti-infective indicated for the treatment of bacterial conjunctivitis.
Development timeline for Zymaxid
|May 19, 2010||Approval Allergan Receives FDA Approval for Zymaxid Ophthalmic Solution|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.